Skip to Main Content

Author Details

Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
1993
246
54
PMIDPaper TitleJournal TitlePublished Year
36194493Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.BMJ Support Palliat Care2023
38023144Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab.Front Oncol2023
37664025Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.Front Oncol2023
38058352Clinical Presentation and Genomic Analysis of HPV-Related Squamous Cell Carcinoma of the Larynx in Two Young Female Patients.Cureus2023
37509217Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.Cancers (Basel)2023
37504318The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.Curr Oncol2023
37777577Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.Br J Cancer2023
37182801A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.Ann Oncol2023
37439809Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.Clin Cancer Res2023
36720658Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study.Eur Urol Oncol2023
36657745Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients.Br J Clin Pharmacol2023
34995124Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.J Clin Oncol2022
35814860Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.Adv Radiat Oncol2022
35715880Lenvatinib in multimodal therapy for unresectable radioactive iodine-naïve differentiated thyroid cancer: A case report with literature review.Cancer Rep (Hoboken)2022
35623007Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.Can Urol Assoc J2022
35482606Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit.Oncologist2022
35482348Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.JAMA Oncol2022
36654621Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley's Toxin Revisited?Cureus2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
36272847UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancer.Urol Oncol2022
33234494Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review.J Geriatr Oncol2021
33830005Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.Can Urol Assoc J2021
33822655Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.J Clin Oncol2021
33620159Impact of pretreatment dihydropyrimidine dehydrogenase genotype-guided fluoropyrimidine dosing on chemotherapy associated adverse events.Clin Transl Sci2021
33729863Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.J Clin Oncol2021
33616314Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.N Engl J Med2021
34820133A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.Can J Kidney Health Dis2021
34399998Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study.Eur Urol2021
34388408Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.Oral Oncol2021
31348750Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline.Can Urol Assoc J2020
33704179Near Miss or Standard of Care? <i>DPYD</i> Screening for Cancer Patients Receiving Fluorouracil.Curr Oncol2020
33704177Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.Curr Oncol2020
32059705Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.BMC Cancer2020
31864959Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.Oral Oncol2020
33168055Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution.Radiat Oncol2020
32940628Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial.JAMA Oncol2020
32795322Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.Radiat Oncol2020
32520705Images - Solitary fibrous tumor of the prostate.Can Urol Assoc J2020
32520499Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.Clin Nucl Med2020
32267828Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.Can Urol Assoc J2020
32459596Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough.J Clin Oncol2020
30648632The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.Eur J Cancer2019
31844556Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.Cancers Head Neck2019
31603413Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.Can Urol Assoc J2019
31308183Successful treatment of nasopharyngeal cancer using radiotherapy with concurrent cetuximab in a patient with Charcot-Marie-Tooth disease.BMJ Case Rep2019
30732962Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.Oral Oncol2019
31059420Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.Can Urol Assoc J2019
31056399A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.Clin Genitourin Cancer2019
30626742Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.JCI Insight2019
29428550A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.Eur Urol Focus2018
  • 1 - 50 of 246

Recommended Authors

Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Career Start Year 2013
Number of shared co-authors 4
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 10
Arun A Azad
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 16
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 9
Paul Hamberg
Franciscus Gasthuis & Vlietland Hospital Rotterdam and Schiedam
Career Start Year 2006
Number of shared co-authors 4
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 7
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Career Start Year 2003
Number of shared co-authors 20
Brian A Costello
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 2
Syed A Hussain
University of Sheffield and Sheffield Teaching Hospitals
Career Start Year 2001
Number of shared co-authors 10
Jes??s Garc??a-Donas
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 2
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 8
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 20
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 11
Primo N Lara
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 23
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 16
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 4
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 12
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 17
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 6
Lance C Pagliaro
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 7
Rosalind Glasspool
University of Glasgow
Career Start Year 1992
Number of shared co-authors 3
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 17
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 4
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 26
Paul Harnett
Westmead Clinical School, University of Sydney
Career Start Year 1986
Number of shared co-authors 0
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 0
David C Smith
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Career Start Year 1985
Number of shared co-authors 16
Maha Hussain
Northwestern University
Career Start Year 1984
Number of shared co-authors 22
Oliver Sartor
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 32
Mario A Eisenberger
Johns Hopkins University
Career Start Year 1977
Number of shared co-authors 24

Collaborators

David A Palma
University of Western Ontario
Co-authored papers 26
John Yoo
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 26
Anthony C Nichols
University of Western Ontario
Co-authored papers 26
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers 23
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 17
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 16
Kim N Chi
University of British Columbia
Co-authored papers 16
John W Barrett
University of Western Ontario
Co-authored papers 14
Joseph L Chin
University of Western Ontario
Co-authored papers 13
Joe S Mymryk
University of Western Ontario
Co-authored papers 12
Sara Kuruvilla
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 11
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 11
Bret Wehrli
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 10
Fred Saad
University of Montreal Health Center
Co-authored papers 10
Keith Kwan
Western University
Co-authored papers 8
Paul C Boutros
University of California los angeles
Co-authored papers 8
Andrew Warner
Western University and London Regional Cancer Program
Co-authored papers 7
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers 7
Christopher J Howlett
Western University
Co-authored papers 6
Peter K Rogan
CytoGnomix Inc.
Co-authored papers 6
Nicole Pinto
School of Public Policy at the University of Calgary
Co-authored papers 6
Urban Emmenegger
Odette Cancer Centre
Co-authored papers 6
Stephen Welch
Victoria Hospital
Co-authored papers 6
Kara M Ruicci
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 5
William Stecho
University of Western Ontario
Co-authored papers 5
Adrian Mendez
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 5
James Koropatnick
Western University, Lawson Health Research Institute
Co-authored papers 5
Farhad Ghasemi
Western University
Co-authored papers 5
Morgan Black
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 5
Neil Mundi
Southern Illinois University School of Medicine
Co-authored papers 5
Release 1.2